Richard E Winter Cancer Treat is categorized under Doctors in Ogdensburg, NY and active since 1999.
Richard E Winter Cancer Treat was established in 1999, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christine Richardson, Office Manager at the company’s single location by writing to 5 Lyon Place, Ogdensburg, New York NY 13669 or by phoning (315) 393-2314. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Richard E Winter Cancer Treat |
| Contact Person: | Christine Richardson, Office Manager |
| Address: | 5 Lyon Place, Ogdensburg, New York 13669 |
| Phone Number: | (315) 393-2314 |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Richard E Winter Cancer Treat was started in 1999 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Christine Richardson, Office Manager for inquiries that concern Richard E Winter Cancer Treat by calling the company number (315) 393-2314, as your correspondence is most welcome. Additionally, the physical location of the single location of Richard E Winter Cancer Treat can be found at the coordinates 44.69077,-75.49924 as well as the street address 5 Lyon Place in Ogdensburg, New York 13669.
For its online presence, you may visit Richard E Winter Cancer Treat’s website at and engage with its social media outlets through on Twitter and on Facebook.